Autopsy report · NCT01014546

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

“low accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 4 years 10 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Roswell Park Cancer Institute

Sponsor type

University, hospital or other

Conditions

Essential Thrombocythemia; Polycythemia Vera; Primary Myelofibrosis

Interventions

Arsenic Trioxide; Ascorbic Acid; Laboratory Biomarker Analysis; Pharmacological Study

Participants

5

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.